From the Desk of the CEO

In August 2024, the American Heart Association (AHA) published a scientific statement that identifies evidence-based gaps in managing elevated inpatient BP, including asymptomatic hypertension and hypertensive emergency.

Terri D’Arrigo

Each year in the United States, approximately 230,000 people are diagnosed with non-small cell lung cancer (NSCLC), accounting for more than 80% of all lung cancer cases. 

Elizabeth Briand

Antimicrobial resistance is now one of the biggest threats to global health—and it’s only set to worsen.

Yara Al-Shaer, PharmD

Older adults who take trimethoprim-sulfamethoxazole (TMPSMX) while on digoxin are at a much higher risk of dangerous adverse effects compared with those who take amoxicillin, according to research published in the July 2024 issue of the Journal of Human Pharmacology and Drug Therapy.

Aiya Almogaber, PharmD

Blood transfusions are commonly administered to patients with acute brain injury, but the optimal hemoglobin transfusion threshold is uncertain in these patients. Members of the TRAIN Randomized Clinical Trial Study Group conducted a multicenter, phase 3, parallel-group, open-label randomized clinical trial to assess the impact on neurological outcome of two different hemoglobin thresholds to guide red blood cell transfusions in patients with acute brain injury.